medline.ch Psychiatrie Schizophrenie und Psychosen

	Influence of syringic acid on schizophrenia in mice: Modulation of PI3K/AKT1/GSK3Î² signaling pathway, galectin-3 and MBP. Int Immunopharmacol Salama A, Elwahab SA, El-Fadaly AA. PMID: 41689874 [PubMed - as supplied by publisher]
	Factors associated with hospitalisations over the two years following first episode psychosis in a remote setting: A retrospective cohort study. Australas Psychiatry Ritchie S, Mitchell D, Bressington D, Taft W, Mirza T. PMID: 41689342 [PubMed - as supplied by publisher]
	Reflections from individuals with schizophrenia on a life with delusions and hallucinations: a phenomenological study. Ann Gen Psychiatry Uzun S, Ediz Ç, Burak Erda. PMID: 41689044 [PubMed - as supplied by publisher]
	Excess mortality and life-years lost in older adults with schizophrenia-spectrum disorders: A 6-year follow-up case-control study. Int Psychogeriatr Fung CCS, Cheng CPW, Chan JKN, Chung TH, Lee ATC, Lam LCW, Sham PC, Wong MC, Chan LK, Tsoi ASH, Wong YC, Poon TK, Chan MC, Tse KTY, Liu HWS, Tang AYS, Cheung SH, Wong CSM, Chang WC, Chan WC. PMID: 41688275 [PubMed - as supplied by publisher]
	Effectiveness of a Combined High-Definition tDCS-Primed Intermittent Theta Burst Stimulation Protocol Targeting the Cerebellar Vermis in Treatment-Resistant Schizophrenia: a Randomized Sham-Controlled Trial. Cerebellum Ranjan A, Garg S, Dhyani M. PMID: 41686308 [PubMed - indexed for MEDLINE]
	Validation of a Traumatic Brain Injury Remediation Programme for Chronic Schizophrenia. Ann Neurosci Mishra SA, Mishra DK. PMID: 41685269 [PubMed - as supplied by publisher]
	Incidence and predictors of problem gambling in first-episode psychosis: a prospective multicentre cohort study. Eur Psychiatry Corbeil O, Huot-Lavoie M, Abdel-Baki A, Béchard L, Brodeur S, Artaud L, Constantinides P, Jacques C, Morin JF, Ouellet-Plamondon C, Solmi M, Talbot D, Dorval M, Giroux I, Roy MA, Demers MF. PMID: 41684270 [PubMed - as supplied by publisher]
	Pharmacological interventions for social cognitive impairments in schizophrenia: A systematic review and network meta-analysis of randomized controlled trials. Eur Psychiatry Yamada Y, Watanabe N, Tomo Y, Tachimori H, Horinouchi T, Uchino T, Kubota R, Okano H, Ishikawa S, Sawagashira R, Takanobu K, Hasegawa Y, Sasaki Y, Nishiuchi M, Sumiyoshi T, Hashimoto N, Ikezawa S, Nemoto T, Okubo R. PMID: 41684115 [PubMed - as supplied by publisher]
	MTHFR and MTRR Polymorphisms Predict Sex-Dependent Psychotic Symptom Improvements, Not Metabolic Changes. Int J Mol Sci Nadalin S, Majdand, Vranekovi, Peitl V, Vilibi, Sili, Karlovi. PMID: 41683775 [PubMed - indexed for MEDLINE]
	Prevalence and associated risk factors of psychotic experiences in the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Ann Gen Psychiatry Fekih-Romdhane F, Azzi V, Harb F, Obeid S, Hallit S. PMID: 41680907 [PubMed]
	Brain texture alterations predict subtle visual perceptual dysfunctions in recent onset psychosis and clinical high-risk state. Transl Psychiatry Lencer R, Sprenger A, Meyhöfer I, Dannlowski U, Romer G, Kambeitz-Ilankovic L, Kambeitz J, Lichtenstein T, Rosen M, Ruhrmann S, Haas SS, Salokangas RKR, Pantelis C, Bonivento C, Schultze-Lutter F, Meisenzahl E, Brambilla P, Bertolino A, Upthegrove R, Davatzikos C, Koutsouleris N, Borgwardt S, Andreou C, Korda A, PRONIA Consortium. PMID: 41680137 [PubMed - as supplied by publisher]
	Mindfulness-based group therapy for auditory hallucination management in schizophrenia: A randomized controlled trial. J Psychiatr Res Yang S, Zhou W, Qin Y, Zheng T, Huang F, Li C, Dai J, Zhou L, Li L, Wu F, Tang Q. PMID: 41679222 [PubMed - as supplied by publisher]
	Latency to Long-Acting Injectable Antipsychotic Initiation and Psychiatric Hospitalization in First-Episode Schizophrenia. J Clin Psychiatry Joo SW, Lee J. PMID: 41678397 [PubMed - indexed for MEDLINE]
	Psychosis: The Utility of Ketamine as a Pharmacological Model of Psychotic-like Symptoms in Rodents: A Review of Dosage Regimens. Biology (Basel) Rice CA, Stackman RW Jr. PMID: 41677693 [PubMed]
	Uncovering novel therapeutics for schizophrenia: a multitarget approach using the CANDO platform. bioRxiv Hu Y, Elefteriou K, Falls Z, Samudrala R. PMID: 41676525 [PubMed]
	Global burden of schizophrenia in 204 countries and regions from 1990 to 2021 and machine learning-based projections to 2036: an analysis of the 2021 global burden of disease study. Front Psychiatry Feng Z, Shan X, Fan B, Yang L, Gong F. PMID: 41675669 [PubMed]
	[Organic etiology in first-episode psychosis : when should it be considered ?]. Rev Med Suisse Salamoni J, Camporesi S, Garcin S, Assal F, Curtis L, Vassallo P, Desmettre T, Prada P, Ambrosetti J. PMID: 41674243 [PubMed - indexed for MEDLINE]
	Neuroradiological abnormalities in individuals with first-episode psychosis - a retrospective cohort study. BMC Psychiatry Khorsandian MC, Bonfiglio G, Schulz KJ, Graetz FC, Hofmann A, Hövel AH, Müller M, Corda C, Homan P, Seifritz E, Burrer A, Spiller TR. PMID: 41673848 [PubMed - as supplied by publisher]
	Phenome-wide association study of P2RX7 identifies schizophrenia and mood disorders as primary associated phenotypes. J Affect Disord Zhu L, Mao Q, Luo Z, Chen B, Zhang Y, Lu X, Liu P, Ji J, Wang X, Wang K, Pan X, Cao Y, Liu N, Zheng J, Wang F, Yang K, Yang F, Yu Z, Hu J, Luo J, Zuo L, Wang Z, Luo X, Guo X. PMID: 41672153 [PubMed - as supplied by publisher]
	Altered resting-state functional connectivity in delusional patients with schizophrenia or schizoaffective disorder: An fMRI study using threshold-free cluster-enhancement. Psychiatry Res Neuroimaging Taghvatalab S, Batouli SAH, Soltanian-Zadeh H, Zarrindast MR, Naghavi HR. PMID: 41671697 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 68029

Seite 1 von 3402



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung